The burgeoning landscape of therapeutic interventions for weight disorders has witnessed considerable attention focused on GLP-3 receptor agonists and, more recently, the dual GIP and GLP-3 agonist retatrutide. While https://janavcyn619631.wikifordummies.com/9237022/glp_3_retatrutide_a_comparative_analysis